To determine whether the newly defined stage 1 hypertension (HTN1) is an independent risk factor for Cesarean in nulliparous patients delivering at ≥ 39w. This is a retrospective cohort study of nulliparous patients delivering ≥39w at one academic medical center from 2016-2019. Exposure was defined as HTN1 (SBP 130-139mmHg and/or DBP 80-89mmHg prior to 20w) and compared to normotensive patients (NBP). Exclusion criteria included ≥ stage 2 HTN, multiple gestation, planned Cesarean, or known fetal anomalies. The primary outcome was Cesarean during labor. Secondary outcomes included hypertensive disorders of pregnancy, operative vaginal delivery, birth weight under 10th%, NICU admission, and a composite of adverse neonatal outcomes including 10 minute Apgar score < 7, assisted ventilation, surfactant use, antibiotics for suspected sepsis, neurologic dysfunction, and significant birth injury. Statistical analysis was performed using SPSS 27. A total of 500 patients were included, 250 with HTN1 and 250 with NBP. At baseline, the groups differed with respect to maternal race, smoking, BMI, and gestational diabetes. A total of 38% patients with HTN1 required Cesarean during labor as compared to 22% with NBP (RR 1.556, 95% CI 1.233 to 1.963, p<0.001). This association remained significant after controlling for gestational age, induction, BMI, age, birth weight, race/ethnicity, diabetes, aspirin, smoking, autoimmune conditions, and other comorbidities in a logistic regression model (OR 1.61, 95%CI 1.02 to 2.55, p<0.040). When stratified based on the indication for Cesarean being nonreassuring fetal status, there was a higher rate of Cesarean in patients with HTN1 (RR 1.347, 95%CI 1.035 to 1.753, p=0.015). Patients with HTN1 did have an increased rate of hypertensive disorders of pregnancy as compared to patients with NBP (RR 1.788, 95%CI 1.303 to 2.452, p<0.001), but there were no significant differences in the other secondary outcomes. In nulliparous patients, HTN1 is an independent risk factor for Cesarean during labor.